We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
Protease-Activated Receptor-2, amide (SLIGKV-NH2) is a highly potent protease-activated receptor-2 (PAR2) activating peptide.
CAT No: R1637
CAS No: 190383-13-2
Synonyms/Alias: SLIGKV-NH2;190383-13-2;H-Ser-Leu-Ile-Gly-Lys-Val-NH2;Ser-Leu-Ile-Gly-Lys-Val-amide;(2S)-6-amino-2-[[2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]acetyl]amino]-N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]hexanamide;(S)-6-Amino-2-(2-((2S,3S)-2-((S)-2-((S)-2-amino-3-hydroxypropanamido)-4-methylpentanamido)-3-methylpentanamido)acetamido)-N-((S)-1-amino-3-methyl-1-oxobutan-2-yl)hexanamide;PAR2 activating peptide;PAR2-AP;PAR-2 (1-6) Human;CHEMBL4084322;Ser-Leu-Ile-Gly-Lys-Val-NH2;BDBM85084;DTXSID70440595;CHEBI:184103;HOWDUIVVWDUEED-WAUHAFJUSA-N;HY-P0283;MFCD02259590;AKOS024457380;DA-57925;FP109317;MS-30734;CAS_190383-13-2;G13125;H-Ser-Leu-Ile-Gly-Lys-Val-NH2; H-SLIGKV-NH2;PAR-2 (1-6) amide (human) trifluoroacetate salt;Ser-Leu-Ile-Gly-Lys-Val-amide, >=95% (HPLC), solid;Protease-activated receptor 2 (PAR2) agonist(SLIGKV-NH2)?;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C28H54N8O7 |
M.W/Mr. | 614.8 |
Sequence | One Letter Code:SLIGKV Three Letter Code:H-Ser-Leu-Ile-Gly-Lys-Val-NH2 |
Biological Activity | Protease-activated receptor 2 (PAR2) agonist (Ki = 9.64 μM and IC50 = 10.4 μM). Corresponds to the tethered ligand exposed by trypsin cleavage of PAR-2. |
Long-term Storage Conditions | Soluble to 1 mg/ml in water |
Shipping Condition | Room temperature in continental US; may vary elsewhere. |
InChI | InChI=1S/C28H54N8O7/c1-7-17(6)23(36-27(42)20(12-15(2)3)34-25(40)18(30)14-37)28(43)32-13-21(38)33-19(10-8-9-11-29)26(41)35-22(16(4)5)24(31)39/h15-20,22-23,37H,7-14,29-30H2,1-6H3,(H2,31,39)(H,32,43)(H,33,38)(H,34,40)(H,35,41)(H,36,42)/t17-,18-,19-,20-,22-,23-/m0/s1 |
InChI Key | HOWDUIVVWDUEED-WAUHAFJUSA-N |
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
4. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com